↓ Skip to main content

Dove Medical Press

FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping

Overview of attention for article published in OncoTargets and therapy, November 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

patent
3 patents

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
25 Mendeley